Dr. Sara Tolaney of the Dana-Farber Cancer Institute joined the show to share her insights on the ASCENT-04 trial recently published in NEJM. This is an RCT in triple-negative breast cancer. Sara led this study and as the lead author, ...

Dr. Ajay Nooka of Emory University and the Winship Cancer Institute joins Healthcare Unfiltered EXPRESS to tell us about CELMoDs in multiple myeloma. What are these agents? How do they work? How do they help patients with myeloma? And what does...

Dr. Kasi from the City of Hope joins the Healthcare Unfiltered EXPRESS for a chat on what intrigued him at the last ASCO GI meeting that took place a few weeks ago. What mattered and did any standards of care changed?Take a listen, share...

Dr. Dan Olson of the University of Chicago joins the Healthcare Unfiltered EXPRESS to discuss the current state of TILs in cancer therapy, specifically in melanoma. Dr. Olson describes the technology, how to deliver, how to mitigate side effect...

Dr. Erika Hamilton from the SCRI joined the show to give timely and important updates on how treating breast cancer may be changing in view of trial data presented at the 2025 December SABCS meeting that just concluded. A must listen episode to...